Therapeutics and Pharmacology PhD student Tyler Bateman is building a foundation in translational research through his work in the lab of his advisor, Ali Azhdarinia, PhD, where he focuses on developing targeted therapies for cancer. 

With a long-standing interest in chemistry and a desire to make an impact through medicine, Bateman sees drug development as a meaningful way to improve patient outcomes and contribute to the future of cancer care. 

His research centers on drug conjugates designed to bind specific receptors on tumor cells, improving the precision and effectiveness of treatment. His work contributes to ongoing efforts to expand therapeutic options for patients with neuroendocrine tumors. 

Beyond the science, Bateman highlights the importance of mentorship and a collaborative lab environment. Working alongside scientists with expertise in cancer biology, pharmacology, and chemistry has allowed him to develop a broad skill set and approach research from multiple perspectives. 

“Each person in my lab brings a different area of expertise — being able to learn from all of them has been really valuable.” 

The guidance he receives from his advisor, faculty and staff — along with opportunities to support students who work in his lab during the summer — continues to shape how Bateman approaches both research and leadership.